Wednesday, 3rd of August 2016 |
Vaccine. 2016 Jul 5. pii: S0264-410X(16)30389-9. doi: 10.1016/j.vaccine.2016.05.063. [Epub ahead of print]
Contribution of polio eradication initiative to effective new vaccine introduction in Africa, 2010-2015
Carole Tevi-Benissan M1, Moturi E2, Anya BM2, Aschalew T2, Dicky AB2, Nyembo PA2, Mbulu LK3, Okeibunor J2, Mihigo R2, Zawaira F2.
Abstract below; full text is at http://www.sciencedirect.com/science/article/pii/S0264410X16303899
BACKGROUND:
Significant progress has been made to increase access to vaccines in Africa since the 1974 launch of the Expanded Programme on Immunization (EPI). Successes include the introduction of several new vaccines across the continent and likely eradication of polio. We examined the contribution of polio eradication activities (PEI) on new vaccine introduction in the countries of the African Region.
METHODS:
We reviewed country specific PEI reports to identify best practices relevant to new vaccine introduction (NVI), and analyzed trends in vaccine coverage during 2010-2015 from immunization estimates provided by WHO/UNICEF.
RESULTS:
Of the 47 countries in African Region 35 (74%) have introduced PCV, 27 (57%) have introduced rotavirus, and 14 (30%) have introduced IPV. National introductions for HPV vaccine have been done in 5 countries, while 15 countries have held demonstration and pilot projects. In 2014, the regional coverage for the third dose of PCV (PCV3) and rotavirus vaccines was 50% and 30% respectively. By end of 2015, all countries within the meningitis belt will have introduced MenAfriVac™ vaccine.
CONCLUSIONS:
PEI activities had a positive effect in strengthening the process of new vaccine introduction in the African Region. The majorcontribution was in availing immunization funding and providing trained and experienced technical staff to introduce vaccines. More investment is needed to advocate and sustain funding levels to maintain the momentum gained in introducing new vaccines in the region.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
40968129 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |